Altogether, these results suggested that YAP1 could be a potential prognostic biomarker in some specific types of cancers and YAP1 over expression was significantly associated with poor prognosis in ACC, LGG, and PAAD. Here, YAP1 is linked to adrenal cortex carcinoma.